Il principale motore di ricerca di sperimentazioni cliniche in Europa
Azienda Unita Sanitaria Locale Toscana Nord Ovest
Sperimentazioni cliniche corrispondenti
Studio sull’efficacia del vaccino HPV 9-valente in donne con neoplasia cervicale intraepiteliale di alto grado o cancro cervicale inizialmente invasivo
Arruolamento concluso
Farmaci in studio:- Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
- Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
- Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
